Elimination rate of N-acetylprocainamide after a single intravenous dose of procainamide hydrochloride in man
- PMID: 1151617
- DOI: 10.1007/BF01066016
Elimination rate of N-acetylprocainamide after a single intravenous dose of procainamide hydrochloride in man
Abstract
Equations were derived which made it possible to determine the elimination rate of N-acetylprocainamide from urinary data after intravenous administration of procainamide hydrochloride. A single dose of 500 mg of the drug was infused intravenously in four healthy subjects. On the basis of theose equations, the formation rate of the metabolite could be calculated presuming that all rate processes were occurring by first-order processes. However, close examination of the excretion rate data appears to support the contention that the formation or excretion of N-acetylprocainamide may be occurring by a saturable process
Similar articles
-
Clinical pharmacokinetics of N-acetylprocainamide.Clin Pharmacokinet. 1982 May-Jun;7(3):206-20. doi: 10.2165/00003088-198207030-00002. Clin Pharmacokinet. 1982. PMID: 6178545 Review.
-
Pharmacokinetics of procainamide and N-acetylprocainamide in rats.J Pharm Sci. 1981 Mar;70(3):299-302. doi: 10.1002/jps.2600700319. J Pharm Sci. 1981. PMID: 6167709
-
The quantitative disposition of procainamide and N-acetylprocainamide in the rat.J Pharmacol Exp Ther. 1978 Jan;204(1):219-25. J Pharmacol Exp Ther. 1978. PMID: 619132
-
Pharmacokinetics of procainamide intravenously and orally as conventional and slow-release tablets.Clin Pharmacol Ther. 1975 Apr;17(4):414-23. doi: 10.1002/cpt1975174414. Clin Pharmacol Ther. 1975. PMID: 1122683
-
Theoretical basis for interest in acetylprocainamide and clinical experiences with this new antiarrhythmic agent.Drug Metab Rev. 1979;10(2):239-46. doi: 10.3109/03602537908997471. Drug Metab Rev. 1979. PMID: 95247 Review.
Cited by
-
Clinical pharmacokinetics of N-acetylprocainamide.Clin Pharmacokinet. 1982 May-Jun;7(3):206-20. doi: 10.2165/00003088-198207030-00002. Clin Pharmacokinet. 1982. PMID: 6178545 Review.
-
Effects of concurrent administration of other substrates of N-acetyltransferase on dapsone acetylation.Br J Clin Pharmacol. 1981 Jul;12(1):83-6. doi: 10.1111/j.1365-2125.1981.tb01860.x. Br J Clin Pharmacol. 1981. PMID: 7248142 Free PMC article. No abstract available.
-
Clinical pharmacokinetics of hydrallazine.Clin Pharmacokinet. 1977 Sep-Oct;2(5):317-29. doi: 10.2165/00003088-197702050-00001. Clin Pharmacokinet. 1977. PMID: 913002 No abstract available.
-
Serum procainamide levels as therapeutic guides.Clin Pharmacokinet. 1977 Nov-Dec;2(6):389-402. doi: 10.2165/00003088-197702060-00001. Clin Pharmacokinet. 1977. PMID: 589880 No abstract available.
-
Effect of N-Acetyltransferase 2 Genotype on the Pharmacokinetics of Hydralazine During Pregnancy.J Clin Pharmacol. 2019 Dec;59(12):1678-1689. doi: 10.1002/jcph.1477. Epub 2019 Jun 30. J Clin Pharmacol. 2019. PMID: 31257615 Free PMC article.